Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
The six-month buprenorphine implant provides a new maintenance treatment option for those in recovery
The man pleaded guilty to a 2015 DUI charge that left two EMTs seriously injured
EMS agencies should promote public involvement in cardiopulmonary resuscitation and AED use to improve community health
The bill would allow first responders to open and manually maintain an airway, administer oxygen and control a hemorrhage
The sensitivity training followed one firefighter’s post that went viral saying drug addicts shouldn’t be given Narcan
Jonathan M. McCulley, 34, is facing multiple charges for allegedly stealing fentanyl, Valium and morphine
W-18 is a novel opioid, more powerful than fentanyl, purchased online from China and legal to possess in the US
End-tidal carbon dioxide is an irrefutable indication for any type of airway adjunct
The new law to sell Narcan over-the-counter also calls for patient counseling and educational materials
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.